MINNEAPOLIS, July 27 Uroplasty, Inc. (Nasdaq: UPI) announced today that it will release financial results for the first quarter ended June 30, 2010, at the market close on Tuesday, August 10, 2010. The Company will host a conference call to discuss these results on Tuesday, August 10, 2010 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 888-549-7750. An audio replay will be available for 30 days following the call at 800-406-7325 (domestic) and 303-590-3030 (international), with the passcode 4337016#.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the continued commercialization of our Urgent® PC System, which we believe is the only FDA-approved minimally invasive neuromodulation device designed for office-based treatment of urinary urgency, urinary frequency and urge incontinence - symptoms often associated with overactive bladder. We also offer Macroplastique®, an injectable bulking agent for the minimally invasive treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Please visit Uroplasty, Inc. at www.uroplasty.com.
For Further Information: ------------------------ Uroplasty, Inc. EVC Group David Kaysen, President and CEO, or Doug Sherk (Investors) Medi Jiwani, Vice President, CFO, and Treasurer, 415.896.6820 952.426.6140 Chris Gale (Media) ------------ 646.201.5431 ------------
SOURCE Uroplasty, Inc.